The pandemic paradox: surviving a public health crisis breeds more science skeptics, researchers find

In a worldwide study, researchers found that vaccine skepticism is rife and trust for scientists is down among those who survived an epidemic.

Source: Fortune | 27 Nov 2020 | 8:16 am

These economic recovery plays still have more room to run, Barclays says

Some economic recovery plays are still undervalued even after positive vaccine news helped boost cyclical stocks, according to a note from Barclays.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 8:07 am

Suspected North Korean hackers reportedly targeted AstraZeneca

Suspected North Korean hackers have tried to break into the systems of British drugmaker AstraZeneca in recent weeks, Reuters reported.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 8:03 am

When second stimulus checks could arrive if Biden strikes a deal

Staffers on Capitol Hill expect a stimulus bill to pass shortly after the inauguration of President-elect Joe Biden. If it includes another round of stimulus checks, here's when those payment could start arriving.

Source: Fortune | 27 Nov 2020 | 8:00 am

These megacities could become breeding grounds for the next pandemic, scientists say

Mumbai, Jakarta and Manila are among the well-connected urban hubs where human-animal interaction is increasingly common, and health risks multiply.

Source: Fortune | 27 Nov 2020 | 8:00 am

China is more concerned by Biden than Trump, economist Jim O'Neill says

Joe Biden's presidency will be a bigger problem for China than the Trump administration, economist Jim O'Neill told CNBC's "Squawk Box Europe" on Friday.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 7:58 am

Stocks making the biggest moves in the premarket: AstraZeneca, Disney, Pfizer, Amazon & more

Names on the move ahead of the open.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 7:51 am

Amazon says it will offer warehouse staff a one time bonus amid union drive

The company said full-time staff would get $300. The company is seeing union organizing and criticism over rolling back its pandemic hazard pay.

Source: Fortune | 27 Nov 2020 | 7:36 am

Who will Biden name as SEC chair? Here are insiders’ best guesses

Preet Bharara and Gary Gensler are names floated in the media, but insiders say they are unlikely picks.

Source: Fortune | 27 Nov 2020 | 7:30 am

One of November's worst-performing stocks could have 30% upside, chart suggests

Hanesbrands appears to be in a stronger position than the S&P 500's other laggards this month, two traders say.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 7:02 am

Main Street pins hopes on Small Business Saturday sales to help stay afloat

It's uncertain how Small Business Saturday on Nov. 28 will move the needle and help the millions of business owners on Main Street struggling to survive.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 6:58 am

U.S. regulators open probe into 115,000 Tesla vehicles over suspension issue

The U.S. National Highway Traffic Safety Administration on Friday said it had opened an investigation into about 115,0000 Tesla vehicles over front suspension safety issues.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 6:29 am

SoftBank stock rides Uber and DoorDash to 20-year high

The Japanese conglomerate shook off the WeWork disaster in 2019 to push to fresh highs this year.

Source: Fortune | 27 Nov 2020 | 5:47 am

Britain tries to cool AstraZeneca concerns as its CEO touts a new vaccine trial

Britain has asked its medicine regulator to assess the vaccine for a temporary supply, which could mean it's rolled out in the country before the end of the year.

Source: Top News and Analysis (pro) | 27 Nov 2020 | 4:52 am

AstraZeneca eyes another global trial for its COVID vaccine following dosage blip

AstraZeneca CEO Pascal Soriot said he didn’t expect the additional trial to hold up regulatory approvals in the U.K. and European Union.

Source: Fortune | 27 Nov 2020 | 4:10 am